Download PDF
Semin intervent Radiol 2013; 30(02): e1
DOI: 10.1055/s-0033-1349396
Erratum
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Non–Small-Cell Lung Cancer: Treatment of Late Stage Disease: Chemotherapeutics and New Frontiers

Ronald J. Scheff
1   Division of Hematology/Oncology, Department of Internal Medicine, Weill Cornell Medical College, New York, New York
,
Bryan J. Schneider
1   Division of Hematology/Oncology, Department of Internal Medicine, Weill Cornell Medical College, New York, New York
› Author Affiliations
Further Information

Address for correspondence

Bryan J. Schneider, MD
Division of Hematology/Oncology, Department of Internal Medicine
Weill Cornell Medical College, 525 East 68th Street, 3rd floor, Payson Pavilion
New York, NY 10065   

Publication History

Publication Date:
24 June 2013 (online)

Also available at
 
 PDF Download Permissions and Reprints

Correction to:

Non–Small-Cell Lung Cancer: Treatment of Late Stage Disease: Chemotherapeutics and New FrontiersSemin intervent Radiol 2013; 30(02): 191-198
DOI: 10.1055/s-0033-1342961

    The publisher regrets an error with the opening sentence in the above article in Seminars in Interventional Radiology, Volume 30, Number 2, 2013. p. 191. The corrected sentence is indicated below.

    “Non-small cell lung cancer (NSCLC), the leading cause of cancer-related mortality in the United States, and a leading cause of cancer-related mortality worldwide, remains a formidable clinical challenge.”


    #

    Address for correspondence

    Bryan J. Schneider, MD
    Division of Hematology/Oncology, Department of Internal Medicine
    Weill Cornell Medical College, 525 East 68th Street, 3rd floor, Payson Pavilion
    New York, NY 10065   

       Permissions and Reprints